{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:13:10Z","timestamp":1789578790319,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["TSG-2020-36834, 2019K12-149071"],"award-info":[{"award-number":["TSG-2020-36834, 2019K12-149071"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Erroneous immune responses in COVID-19 could have detrimental effects, which makes investigation of immune network underlying COVID-19 pathogenesis a requisite. This study aimed to investigate COVID-19 related alterations within the frame of innate and adaptive immunity. Thirty-four patients clinically diagnosed with mild, moderate and severe COVID-19 disease were enrolled in this study. Decreased ILC1 and increased ILC2 subsets were detected in mild and moderate patients compared to healthy controls. NK cell subsets and cytotoxic capacity of NK cells were decreased in severe patients. Moreover, CD3<jats:sup>+<\/jats:sup> T cells were reduced in severe patients and a negative correlation was found between CD3<jats:sup>+<\/jats:sup> T cells and D-dimer levels. Likewise, moderate and severe patients showed diminished CD3<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells. Unlike T and NK cells, plasmablast and plasma cells were elevated in patients and IgG and IgA levels were particularly increased in severe patients. Severe patients also showed elevated serum levels of pro-inflammatory cytokines such as TNF-\u03b1, IL-6 and IL-8, reduced intracellular IFN-\u03b3 and increased intracellular IL-10 levels. Our findings emphasize that SARS-CoV-2 infection significantly alters immune responses and innate and acquired immunity are differentially modulated in line with the clinical severity of the disease. Elevation of IL-10 levels in NK cells and reduction of CD3<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells in severe patients might be considered as a protective response against the harmful effect of cytokine storm seen in COVID-19.<\/jats:p>","DOI":"10.3389\/fimmu.2022.954391","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T04:47:21Z","timestamp":1661834841000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Immune modulation as a consequence of SARS-CoV-2 infection"],"prefix":"10.3389","volume":"13","author":[{"given":"Metin Yusuf","family":"Gelmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Betul","family":"Oktelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Tahrali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut Can","family":"Kucuksezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilgun","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin Aktas","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Savran","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Besisik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"Koksalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naci","family":"Senkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"B1","first-page":"77","article-title":"Initial complete blood count score and predicting disease progression in COVID-19 patients","volume":"11","author":"Ozbalak","year":"2021","journal-title":"Am J Blood Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1038\/s41598-021-85869-0","article-title":"Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study","volume":"11","author":"Zhai","year":"2021","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.05.041","article-title":"Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study","volume":"26","author":"Cen","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611004","article-title":"B cell subsets as severity-associated signatures in COVID-19 patients","volume":"11","author":"Sosa-Hernandez","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104363","DOI":"10.1016\/j.cellimm.2021.104363","article-title":"Functional responsiveness of memory T cells from COVID-19 patients","volume":"365","author":"Tavukcuoglu","year":"2021","journal-title":"Cell Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24172","article-title":"Lymphocyte subset counts in COVID-19 patients: A meta-analysis","volume":"97","author":"Huang","year":"2020","journal-title":"Cytometry A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"110859","DOI":"10.1016\/j.biopha.2020.110859","article-title":"Innate and adaptive immune responses against coronavirus","volume":"132","author":"Hosseini","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622306","article-title":"The role of natural killer cells in autoimmune diseases","volume":"12","author":"Kucuksezer","year":"2021","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.05.013","article-title":"Innate lymphoid cells: Diversity, plasticity, and unique functions in immunity","volume":"48","author":"Colonna","year":"2018","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12712","article-title":"Innate lymphoid cells in lung infection and immunity","volume":"286","author":"Stehle","year":"2018","journal-title":"Immunol Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1366314","article-title":"Innate lymphoid cells: the role in respiratory infections and lung tissue damage","volume":"13","author":"Globinska","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.030","article-title":"Natural killer cells in patients with allergic diseases","volume":"132","author":"Deniz","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.15.383323","article-title":"Immunological memory to SARS-CoV-2 assessed for up to eight months after infection","author":"Dan","year":"2020","journal-title":"bioRxiv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244126","article-title":"Antibody response to SARS-CoV-2 infection in humans: A systematic review","volume":"15","author":"Post","year":"2020","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00671-y","article-title":"Emerging treatment strategies for COVID-19 infection","volume":"21","author":"Gavriatopoulou","year":"2021","journal-title":"Clin Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2004-168","article-title":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk J Med Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2020.07.001","article-title":"Immune response in COVID-19: A review","volume":"13","author":"Chowdhury","year":"2020","journal-title":"J Infect Public Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12967","article-title":"Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms","volume":"93","author":"Jafarzadeh","year":"2021","journal-title":"Scand J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: The current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.5152\/TurkThoracJ.2020.20125","article-title":"COVID-19 treatment at a glance","volume":"21","author":"Ar\u0131kan","year":"2020","journal-title":"Turk Thorac J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.04.002","article-title":"Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections","volume":"54","author":"Harb","year":"2021","journal-title":"Immunity"},{"key":"B25","unstructured":"Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131TC\n          COVID-19 bilgilendirme platformu2022"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","volume":"254","author":"Aktas","year":"2009","journal-title":"Cell Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02179","article-title":"Imbalance of circulating innate lymphoid cell subpopulations in patients with septic shock","volume":"10","author":"Carvelli","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12998","article-title":"Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management","volume":"93","author":"Anka","year":"2021","journal-title":"Scand J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000513288","article-title":"The association between presence of comorbidities and COVID-19 severity: A systematic review and meta-analysis","volume":"50","author":"Honardoost","year":"2021","journal-title":"Cerebrovasc Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00608","article-title":"COVID-19 transmission, current treatment, and future therapeutic strategies","volume":"18","author":"Salian","year":"2021","journal-title":"Mol Pharm"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.3390\/cells10113182","article-title":"NK and T cell immunological signatures in hospitalized patients with COVID-19","volume":"10","author":"Bergantini","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12879-021-06354-7","article-title":"Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.14.21249839","article-title":"Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection","author":"Silverstein","year":"2021","journal-title":"medRxiv"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41598-020-58326-7","article-title":"Unique natural killer cell subpopulations are associated with exacerbation risk in chronic obstructive pulmonary disease","volume":"10","author":"Osterburg","year":"2020","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.586078","article-title":"The role of type 2 innate lymphoid cells in allergic diseases","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13547","article-title":"Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain","volume":"203","author":"Cantenys-Molina","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27294","article-title":"Analysis of serum cytokine and protective vitamin d levels in severe cases of COVID-19","volume":"94","author":"Bayraktar","year":"2022","journal-title":"J Med Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.59534","article-title":"The role of CD4(+)FoxP3(+) regulatory T cells in the immunopathogenesis of COVID-19: Implications for treatment","volume":"17","author":"Wang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215266","article-title":"Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19","volume":"76","author":"Khan","year":"2021","journal-title":"Thorax"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26698","article-title":"Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection","volume":"93","author":"Ivan Hariyanto","year":"2021","journal-title":"J Med Virol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1186\/s12879-020-05701-4","article-title":"Effects of tocilizumab in COVID-19 patients: A cohort study","volume":"20","author":"Vu","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/ijms23052665","article-title":"COVID-19 pandemic: Escape of pathogenic variants and MHC evolution","volume":"23","author":"Pontarotti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"9348697","DOI":"10.1155\/2021\/9348697","article-title":"Global meta-analysis on the association between behcet syndrome and polymorphisms from the HLA class I (A, b, and c) and class II (DRB1, DQB1, and DPB1) genes","volume":"2021","author":"Capittini","year":"2021","journal-title":"Dis Markers"},{"key":"B48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/sji.12329","article-title":"Clinical role of human leukocyte antigen in health and disease","volume":"82","author":"Mosaad","year":"2015","journal-title":"Scand J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/tan.14560","article-title":"Association of HLA gene polymorphism with susceptibility, severity, and mortality of COVID-19: A systematic review","volume":"99","author":"Deb","year":"2022","journal-title":"HLA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742881","article-title":"MHC variants associated with symptomatic versus asymptomatic SARS-CoV-2 infection in highly exposed individuals","volume":"12","author":"Castelli","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.954391\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T04:47:30Z","timestamp":1661834850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.954391\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2022.954391"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.954391","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"article-number":"954391"}}